-+ 0.00%
-+ 0.00%
-+ 0.00%

GILEAD SCIENCES EXERCISES OPTION TO LICENSE ASSEMBLY BIOSCIENCES’ HELICASE-PRIMASE INHIBITOR PROGRAMS FOR RECURRENT GENITAL HERPES

Reuters·12/22/2025 13:00:02

Please log in to view news